EvaluatePharma
Warning sounded on pharma’s long-term sales prospects
Analysts at EvaluatePharma downgrade their projections in face of pricing pressures and biosimilar competition
Global pharma market forecast to reach $1.12tr by 2022
Annual growth of 6.3 per cent expected and biologics are set to occupy a stronger position
Pharma set for a strong 2015 as drug sales jump
Industry looking to put the recent ‘horror’ patent expiry years behind it